References
- Vermorken JB, Kapteijn TS, Hart AAM, Pinedo HM. Ototoxicity of cis-diamminedichloroplatintm (II): Influ-ence of dose, schedule and mode of administration. Eur J Cancer Clin Oncol 1983; 19: 53–8.
- Lerner SA, Schmitt BA, Seligsohn R, Matz GJ. Compar-ative study of ototoxicity and nephrotoxicity in patients randomly assigned to treatment with amikacin and gentamicin. Am J Med 1986; 80 (Suppl 6B): 98–104.
- Laurell G, Jungnelius U. High-dose cisplatin treatment: hearing loss and plasma concentrations Laryngoscope 1990; 100: 724–34.
- Sterkers O, Ferrary E, Saumon G, Amiel C. Na and nonelectrolyte entry into inner ear fluids of the rat. Am J Physiol 1987; 253: F50–8.
- Salt AN, Ohyama K, Thalmann R. Radial communica-tion between the perilymphatic scalae of the cochlea. II: Estimation by bolus injection of tracer into the sealed cochlea. Hear Res 1991; 56: 37–43.
- Laurell G, Teixeira M, Sterkets 0, Ferrary E. Paracellular transport properties of inner ear barriers do not account for cisplatin toxicity in the rat. Hear Res 1997; 110: 135–40.
- Todd JH, Seno DA, Hozen-Martin DJ, Sens MA. Aminoglycoside antibiotics alter the paracellular trans-port properties of cultured human proximal tubule cells. Toxicol Pathol 1994; 7: 393–402.
- Soulban G, Smolen sky MH, Yonovitz A. Gentamicin-in-duced chronotoxicity: use of body temperature as a circadian marker rhythm. Chronobiol Int 1990; 7: 393–402.
- Johnsson A, Olsson C, Nygren 0, Nilsson M, Seiving B, Cavallin-Stähl E. Pharmacokinetics and tissue distribu-tion of cisplatin in nude mice: platinum levels and cisplatin-DNA adducts. Cancer Chemother Pharmacol 1995; 37: 23–31.
- Sterkets 0, Saumon G, Tran Ba Huy P, Amiel C. K, Cl, and H20 entry in endolymph, perilymph and cere-brospinal fluid of the rat. Am J Physiol 1982; 243: F173–80.
- Johnson A-C, Canlon B. Progressive hair cell loss induced by toluene exposure. Hear Res 1994; 75: 201–8.
- Laurell G, Engstrom B. The ototoxic effect of cisplatin on guinea pigs in relation to dosage. Hear Res 1989; 38: 27–34.
- Wright CG, Schaefer SD. Inner ear histopathology in patients treated with cis-platinum. Laryngoscope 1982; 92: 1408–13.
- Ravi R, Somani SM, Rybak LP. Mechanism of cisplatin ototoxicity: antioxidant system. PharmacolToxico11995; 76: 386–94.
- Lum H, Malik AB. Regulation of vascular endothelial barrier function. Am J Physiol 1994; 267: L233–41.
- Suzuki M, Kitamura K, Nomura Y. Influence of changed blood pH on anionic sites in the labyrinth. Acta Otolar-yngol (Stockh) 1995; 115: 747–53.
- Suzuki M, Kaga K. Effect of cisplatin on the basement membrane anionic sites in the ampulla, macula, and stria vascularis ofguinea pigs. Ann OtolRhinolLaryngo11997; 106: 971–5.
- Muller M. Frequency representation in the rat cochlea. Hear Res 1991; 51: 247–54.
- Kociba RJ, Sleight SD. Acute toxicologic and pathologic effects of cis-diamminedichloroplatintm (NSC-119875) in the male rat. Cancer Chemother Rep 1971; 55: 1–8.
- Morino T, Sano K, Hara H, et al. Toxicological studies on isepamicin (HAPA-B). I. Acute toxicity test in the mouse, rat and dog. Jpn J Antibiot 1986; 39: 3164–78.
- Lavernhe-Lemaire M-C, Garand G. Ototoxicité a long terme de la gentamicine chez le rat: recherche d'une atteinte rétro-co chldaire par l'étude des potentiels évoqués auditifs du tronc cérébral. Arch Int Physiol Biochim 1985; 93: 7–18.